Relationship of vitamin D, HIV, HIV treatment, and lipid levels in the women's interagency HIV study of HIV-infected and uninfected women in the United States

Janice B. Schwartz, Kelly L. Moore, Michael Yin, Anjali Sharma, Dan Merenstein, Talat Islam, Elizabeth T. Golub, Phyllis C. Tien, Oluwatoyin M. Adeyemi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Relationships between vitamin D, lipids, HIV infection, and HIV treatment (±antiretroviral therapy [ART]) were investigated with Women's Interagency HIV Study data (n = 1758 middle-aged women) using multivariable regression. Sixty-three percent of women had vitamin D deficiency. Median 25-hydroxyvitamin D (25-OH vitamin D) was highest in HIV-infected + ART-treated women (17 ng/mL; P <.001) and was the same in HIV-uninfected or HIV-infected women without ART (14 ng/mL). Vitamin D levels were lower if efavirenz (EFV) was included in ART (15 versus 19 ng/mL; P <.001). The most common lipid abnormality was high triglycerides (≥ 200 mg/dL) in HIV-infected + ART-treated women (13% versus 7% of HIV-infected without ART and 5% of HIV-uninfected; P <.001), with a positive relationship between 25-OH vitamin D and triglycerides (95% confidence interval 0.32-1.69; P <.01). No relationships between 25-OH vitamin D and cholesterol were detected. Vitamin D deficiency is common irrespective of HIV status but influenced by HIV treatment. Similarly, vitamin D levels were positively related to triglycerides only in ART-treated HIV-infected women and unrelated to cholesterol.

Original languageEnglish (US)
Pages (from-to)250-259
Number of pages10
JournalJournal of the International Association of Providers of AIDS Care
Volume13
Issue number3
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Vitamin D
HIV
Lipids
Therapeutics
Triglycerides
Vitamin D Deficiency
efavirenz
Cholesterol
HIV Infections
Confidence Intervals

Keywords

  • 25-OH vitamin D
  • cholesterol
  • HIV infected
  • HIV uninfected
  • LDL cholesterol
  • lipids
  • triglycerides
  • vitamin D
  • WIHS

ASJC Scopus subject areas

  • Immunology
  • Dermatology
  • Infectious Diseases

Cite this

Relationship of vitamin D, HIV, HIV treatment, and lipid levels in the women's interagency HIV study of HIV-infected and uninfected women in the United States. / Schwartz, Janice B.; Moore, Kelly L.; Yin, Michael; Sharma, Anjali; Merenstein, Dan; Islam, Talat; Golub, Elizabeth T.; Tien, Phyllis C.; Adeyemi, Oluwatoyin M.

In: Journal of the International Association of Providers of AIDS Care, Vol. 13, No. 3, 2014, p. 250-259.

Research output: Contribution to journalArticle

Schwartz, Janice B. ; Moore, Kelly L. ; Yin, Michael ; Sharma, Anjali ; Merenstein, Dan ; Islam, Talat ; Golub, Elizabeth T. ; Tien, Phyllis C. ; Adeyemi, Oluwatoyin M. / Relationship of vitamin D, HIV, HIV treatment, and lipid levels in the women's interagency HIV study of HIV-infected and uninfected women in the United States. In: Journal of the International Association of Providers of AIDS Care. 2014 ; Vol. 13, No. 3. pp. 250-259.
@article{e34eff82fdbd442cbb82ffb4e2076d4e,
title = "Relationship of vitamin D, HIV, HIV treatment, and lipid levels in the women's interagency HIV study of HIV-infected and uninfected women in the United States",
abstract = "Relationships between vitamin D, lipids, HIV infection, and HIV treatment (±antiretroviral therapy [ART]) were investigated with Women's Interagency HIV Study data (n = 1758 middle-aged women) using multivariable regression. Sixty-three percent of women had vitamin D deficiency. Median 25-hydroxyvitamin D (25-OH vitamin D) was highest in HIV-infected + ART-treated women (17 ng/mL; P <.001) and was the same in HIV-uninfected or HIV-infected women without ART (14 ng/mL). Vitamin D levels were lower if efavirenz (EFV) was included in ART (15 versus 19 ng/mL; P <.001). The most common lipid abnormality was high triglycerides ({\^a}‰¥ 200 mg/dL) in HIV-infected + ART-treated women (13{\%} versus 7{\%} of HIV-infected without ART and 5{\%} of HIV-uninfected; P <.001), with a positive relationship between 25-OH vitamin D and triglycerides (95{\%} confidence interval 0.32-1.69; P <.01). No relationships between 25-OH vitamin D and cholesterol were detected. Vitamin D deficiency is common irrespective of HIV status but influenced by HIV treatment. Similarly, vitamin D levels were positively related to triglycerides only in ART-treated HIV-infected women and unrelated to cholesterol.",
keywords = "25-OH vitamin D, cholesterol, HIV infected, HIV uninfected, LDL cholesterol, lipids, triglycerides, vitamin D, WIHS",
author = "Schwartz, {Janice B.} and Moore, {Kelly L.} and Michael Yin and Anjali Sharma and Dan Merenstein and Talat Islam and Golub, {Elizabeth T.} and Tien, {Phyllis C.} and Adeyemi, {Oluwatoyin M.}",
year = "2014",
doi = "10.1177/2325957413506748",
language = "English (US)",
volume = "13",
pages = "250--259",
journal = "Journal of the International Association of Providers of AIDS Care",
issn = "2325-9574",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Relationship of vitamin D, HIV, HIV treatment, and lipid levels in the women's interagency HIV study of HIV-infected and uninfected women in the United States

AU - Schwartz, Janice B.

AU - Moore, Kelly L.

AU - Yin, Michael

AU - Sharma, Anjali

AU - Merenstein, Dan

AU - Islam, Talat

AU - Golub, Elizabeth T.

AU - Tien, Phyllis C.

AU - Adeyemi, Oluwatoyin M.

PY - 2014

Y1 - 2014

N2 - Relationships between vitamin D, lipids, HIV infection, and HIV treatment (±antiretroviral therapy [ART]) were investigated with Women's Interagency HIV Study data (n = 1758 middle-aged women) using multivariable regression. Sixty-three percent of women had vitamin D deficiency. Median 25-hydroxyvitamin D (25-OH vitamin D) was highest in HIV-infected + ART-treated women (17 ng/mL; P <.001) and was the same in HIV-uninfected or HIV-infected women without ART (14 ng/mL). Vitamin D levels were lower if efavirenz (EFV) was included in ART (15 versus 19 ng/mL; P <.001). The most common lipid abnormality was high triglycerides (≥ 200 mg/dL) in HIV-infected + ART-treated women (13% versus 7% of HIV-infected without ART and 5% of HIV-uninfected; P <.001), with a positive relationship between 25-OH vitamin D and triglycerides (95% confidence interval 0.32-1.69; P <.01). No relationships between 25-OH vitamin D and cholesterol were detected. Vitamin D deficiency is common irrespective of HIV status but influenced by HIV treatment. Similarly, vitamin D levels were positively related to triglycerides only in ART-treated HIV-infected women and unrelated to cholesterol.

AB - Relationships between vitamin D, lipids, HIV infection, and HIV treatment (±antiretroviral therapy [ART]) were investigated with Women's Interagency HIV Study data (n = 1758 middle-aged women) using multivariable regression. Sixty-three percent of women had vitamin D deficiency. Median 25-hydroxyvitamin D (25-OH vitamin D) was highest in HIV-infected + ART-treated women (17 ng/mL; P <.001) and was the same in HIV-uninfected or HIV-infected women without ART (14 ng/mL). Vitamin D levels were lower if efavirenz (EFV) was included in ART (15 versus 19 ng/mL; P <.001). The most common lipid abnormality was high triglycerides (≥ 200 mg/dL) in HIV-infected + ART-treated women (13% versus 7% of HIV-infected without ART and 5% of HIV-uninfected; P <.001), with a positive relationship between 25-OH vitamin D and triglycerides (95% confidence interval 0.32-1.69; P <.01). No relationships between 25-OH vitamin D and cholesterol were detected. Vitamin D deficiency is common irrespective of HIV status but influenced by HIV treatment. Similarly, vitamin D levels were positively related to triglycerides only in ART-treated HIV-infected women and unrelated to cholesterol.

KW - 25-OH vitamin D

KW - cholesterol

KW - HIV infected

KW - HIV uninfected

KW - LDL cholesterol

KW - lipids

KW - triglycerides

KW - vitamin D

KW - WIHS

UR - http://www.scopus.com/inward/record.url?scp=84900338845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900338845&partnerID=8YFLogxK

U2 - 10.1177/2325957413506748

DO - 10.1177/2325957413506748

M3 - Article

C2 - 24668135

AN - SCOPUS:84900338845

VL - 13

SP - 250

EP - 259

JO - Journal of the International Association of Providers of AIDS Care

JF - Journal of the International Association of Providers of AIDS Care

SN - 2325-9574

IS - 3

ER -